PT - JOURNAL ARTICLE AU - Duan, Rui AU - Chen, Zhaoyi AU - Tong, Jiayi AU - Luo, Chongliang AU - Lyu, Tianchen AU - Tao, Cui AU - Maraganore, Demetrius AU - Bian, Jiang AU - Chen, Yong TI - Leverage Real-world Longitudinal Data in Large Clinical Research Networks for Alzheimer’s Disease and Related Dementia (ADRD) AID - 10.1101/2020.08.03.20167619 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.03.20167619 4099 - http://medrxiv.org/content/early/2020/08/04/2020.08.03.20167619.short 4100 - http://medrxiv.org/content/early/2020/08/04/2020.08.03.20167619.full AB - With vast amounts of patients’ medical information, electronic health records (EHRs) are becoming one of the most important data sources in biomedical and health care research. Effectively integrating data from multiple clinical sites can help provide more generalized real-world evidence that is clinically meaningful. To analyze the clinical data from multiple sites, distributed algorithms are developed to protect patient privacy without sharing individual-level medical information. In this paper, we applied the One-shot Distributed Algorithm for Cox proportional hazard model (ODAC) to the longitudinal data from the OneFlorida Clinical Research Consortium to demonstrate the feasibility of implementing the distributed algorithms in large research networks. We studied the associations between the clinical risk factors and Alzheimer’s disease and related dementia (ADRD) onsets to advance clinical research on our understanding of the complex risk factors of ADRD and ultimately improve the care of ADRD patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by NIH grants 1R01AI130460, 1R01LM012607, R01CA246418, R21AG061431 and UL1TR001427, and PCORI grants ME-2018C3-14754. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and PCORI.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A